7
Participants
Start Date
June 30, 2013
Primary Completion Date
December 31, 2016
Study Completion Date
December 31, 2016
Aurixim
Administration will be performed once a week during 4-week induction period, and then once per 12 weeks during supporting period, if necessary. Total maximum duration of the investigational therapy - 1 year, during which patients will receive up to 8 infusions of Aurixim.
"Federal State Budgetary Institution National Medical-Surgical Center n.a. N.I.Pirogov of the Ministry of Health of the Russian Federation", Moscow
"Federal State Budgetary Institution Russian Oncological Scientific Center n.a. N.N.Blokhin of the Russian Academy of Medical Sciences", Moscow
"State Budgetary Public Healthcare Institution of the Nizhni Novgorod Region Hospital of Ambulance of Dzerzhinsk city", Dzerzhinsk
Biointegrator LLC
INDUSTRY